Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

ANI Pharma Inc (ANIP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 816,296
  • Shares Outstanding, K 11,851
  • Annual Sales, $ 201,580 K
  • Annual Income, $ 15,490 K
  • 60-Month Beta 2.42
  • Price/Sales 4.06
  • Price/Cash Flow 9.30
  • Price/Book 4.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 1.03
  • Number of Estimates 1
  • High Estimate 1.03
  • Low Estimate 1.03
  • Prior Year 1.23
  • Growth Rate Est. (year over year) -16.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
63.01 +9.32%
on 03/19/19
71.39 -3.52%
on 04/01/19
+5.49 (+8.66%)
since 03/18/19
3-Month
51.89 +32.74%
on 01/23/19
71.39 -3.52%
on 04/01/19
+14.21 (+25.99%)
since 01/18/19
52-Week
36.92 +86.57%
on 12/24/18
72.81 -5.39%
on 07/06/18
+7.25 (+11.76%)
since 04/18/18

Most Recent Stories

More News
ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, ANI Pharmaceuticals (ANIP) closed at $68.88, marking a -0.17% move from the previous day.

ANIP : 68.88 (-0.17%)
Ultragenyx's (RARE) UX007 Gets Fast Track Status by FDA

Ultragenyx???s (RARE) UX007 receives Fast Track designation and Rare Pediatric Disease designation by the FDA for the treatment of long-chain fatty acid oxidation disorders.

BAYRY : 17.1800 (-0.69%)
RARE : 64.43 (-0.43%)
ANIP : 68.88 (-0.17%)
CLSN : 2.34 (+3.54%)
QIAGEN Drives Molecular Diagnostics Suite With New Test Kit

QIAGEN (QGEN) introduces the FDA approved companion diagnostic test to help in guiding therapy in any cancer identification.

ADXS : 3.31 (+0.30%)
QGEN : 38.30 (-0.60%)
ANIP : 68.88 (-0.17%)
XRAY : 49.73 (+1.99%)
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?

Is (ANIP) Outperforming Other Medical Stocks This Year?

ANIP : 68.88 (-0.17%)
3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)

ANI (ANIP) could produce exceptional returns because of its solid growth attributes.

ANIP : 68.88 (-0.17%)
ANI Pharmaceuticals Expands Injectable Portfolio with Distribution Agreement for FDA Approved Injectable Product

ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced that it has entered into a Distribution Agreement with a U.S. based injectable manufacturer to commercialize a unique specialty...

ANIP : 68.88 (-0.17%)
ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, ANI Pharmaceuticals (ANIP) closed at $69.44, marking a +1.71% move from the previous day.

ANIP : 68.88 (-0.17%)
Ani Pharmaceutic Up 43.8% Since SmarTrend Uptrend Call (ANIP)

SmarTrend identified an Uptrend for Ani Pharmaceutic (NASDAQ:ANIP) on January 4th, 2019 at $48.01. In approximately 3 months, Ani Pharmaceutic has returned 43.85% as of today's recent price of $69.06....

ANIP : 68.88 (-0.17%)
5 Stocks With Increasing Cash Flows to Scoop Up Big Gains

Cash gives a company vitality and strength. It holds the key to its existence, development and success, and can indeed be referred to as its lifeblood.

FBP : 11.43 (-0.09%)
BBSI : 75.68 (-2.32%)
ANIP : 68.88 (-0.17%)
KMDA : 6.17 (-1.44%)
WD : 53.14 (-0.56%)
Zacks.com featured expert Kevin Matras highlights: Herc, ANI Pharmaceuticals, Kamada, SP Plus and SkyWest

Zacks.com featured expert Kevin Matras highlights: Herc, ANI Pharmaceuticals, Kamada, SP Plus and SkyWest

SKYW : 59.25 (-0.65%)
ANIP : 68.88 (-0.17%)
KMDA : 6.17 (-1.44%)
SP : 34.37 (-0.61%)
HRI : 46.26 (+8.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade ANIP with:

Business Summary

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone...

See More

Key Turning Points

2nd Resistance Point 71.80
1st Resistance Point 70.34
Last Price 68.88
1st Support Level 67.83
2nd Support Level 66.78

See More

52-Week High 72.81
Last Price 68.88
Fibonacci 61.8% 59.10
Fibonacci 50% 54.86
Fibonacci 38.2% 50.63
52-Week Low 36.92

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar